Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 01002078

CERILLIANT™ Tiagabine Hydrochloride Solution, 1.0 mg/mL in Methanol (as free base), Sold by MilliporeSigma™ Supelco™

Catalog No. 01002078 Shop All MilliporeSigma Supelco Products
Change view
Click to view available options
Quantity:
1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
01-002-078 1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 01-002-078 Supplier MilliporeSigma Supelco Supplier No. T0811ML
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Description

Certified reference material

Tiagabine, marketed as the antiepileptic drug Gabitril™, is used in the treatment of anxiety disorders and neuropathic pain including fibromyalgia. The drug also has been approved by US FDA as an adjunctive treatment for partial seizures in ages 12 and up. This Certified Spiking Solution™ is suitable for use in LC/MS or GC/MS applications including forensic analysis, clinical toxicology, prescription monitoring, urine drug testing or pharmaceutical research.
TRUSTED_SUSTAINABILITY

Specifications

CAS 67-56-1, 145821-59-6
Linear Formula C20H26ClNO2S2
MDL Number MFCD07369025
UN Number UN 1230 - class 3 - PG 2 - Methanol, solution
Concentration 1.0 mg/mL in methanol (as free base)
Formula Weight 412.01
Packaging Ampule
Quantity 1 mL
Flash Point 9.7°C (49.5°F) - closed cup

CERILLIANT is a registered trademark of Cerilliant Corporation

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.